REGISTRATION DESK
Ballroom Foyer

SPEAKER READY ROOM
Meeting Room 21

CONTINENTAL BREAKFAST, VISIT EXHIBITS
Ballroom B

EXHIBIT HALL
Ballroom B

INTRODUCTION & WELCOME
Ballroom C

Arthur E. Tarantino
NEAUA President

John H. Lynch, MD; President
AUA President-Elect

SCIENTIFIC SESSION I: ONCOLOGY/LAPAROSCOPY & ROBOTICS
Ballroom C (6 minute presentation, 2 minute discussion)
Moderators: Shaun Wason, MD; Jennifer Yates, MD

1. Narcotic Use after Robotic Urologic Surgery - Are We Overprescribing?
Joan C. Delto, MD¹; Kristian D. Stensland, MD; MPH²; Aaron Berkenwald, MD²; Lauren Dewey, BS¹; Kyle McAnally, BS¹; Jodi Mechaber, NP¹; Analesa Baraka, NP¹; Brian Holliday, PA-C¹; Alireza Moinzadeh, MD²; David Canes, MD²; Sara Hyde, BS¹; Peter Chang, MD; MPH¹; Andrew A. Wagner, MD; MPH^1
1Beth Israel Deaconess Medical Center, Boston, MA; ²Lahey Medical Center, Burlington, MA

2. Long-term Oncologic Comparison of Radiofrequency Ablation to Partial Nephrectomy for T1 Renal Cell Carcinoma using Propensity Score Analysis
Naren Nimmagadda, MD¹; Yichuan G. Hsieh, PhD¹; David Kuppermann, MD¹; Michael Grant, MD¹; Sarah Psutka, MD²; Christopher B. Allard, MD³; Francis McGovern, MD¹; Douglas Dahl, MD¹; Michael Blute, MD¹; Ronald Arellano, MD¹; Debra Gervais, MD¹; Adam Feldman, MD; MPH^1
1Massachusetts General Hospital, Boston, MA; ²Northwestern University Feinberg School of Medicine, Chicago, IL; ³McMaster University, Hamilton, ON

3. Utility of microRNA to Predict Bladder Recurrence after Nephroureterectomy for Upper Tract Urothelial Carcinoma
Alison Levy, MD¹; Travis Sullivan, PhD¹, Kristian Stensland, MD¹; Eric Burks, MD¹; Brendan Browne, MD¹; Chintan Patel, MD¹; Joshua Warrick, MD²; Jay Raman, MD²; David Canes, MD¹; Kimberly Rieger-Christ, PhD^1
1Lahey Hospital, Burlington, MA; ²Penn State Health, Hershey, PA

4. Factors Associated with Readmissions after Radical Cystectomy
Christine Cumarasamy-White, MD; Jacob Baber, MD; Ilene Staff, PhD, Kevin Pinto, BS; Joseph Tortora, MS, Tara McLaughlin, PhD, Mika Gauger, BS; Akshay Gangakhedkar, BS; Anoop Meraney, MD
Hartford Hospital, Hartford, CT

5. A National Study of Risk-aligned Bladder Cancer Surveillance - Recommended but Rarely Practiced
Florian R. Schroeck, MD; MS¹; Kristine E. Lynch, PhD²; Ji Won Chang, MPH²; Todd A. MacKenzie, PhD¹; John D. Seigne, MB¹; Douglas J. Robertson, MD; MPH¹; Philip P. Goodney, MD; MS¹; Brenda Sirovich, MD; MS^1
1Dartmouth-Hitchcock Medical Center, Lebanon, NH; ²VA Salt Lake City Health Care System and University of Utah, Salt Lake City, UT

6. Complications and Survival of Primary Cystectomy, Primary Cystectomy with History of Pelvic or Abdominal Radiation and Salvage Cystectomy after Trimodality Therapy
Alberto Pieretti, MD; Ross Krasnow, MD; Naren Nimmagadda, MD; Adam Feldman, MD MPH; Matthew Wszolek, MD
Massachusetts General Hospital, Brookline, MA

7. Intravesical Docetaxel for the Management of High-Risk Non-Muscle Invasive Bladder Cancer (NMIBC) Following Failed BCG Therapy
Govind Shantharam, BA¹; Jorge Pereira, MD¹; Ohad Kott, MD²; Christopher Tucci, MS, RN²; Ali Amin, MD²; Anthony Mega, MD²; Dragan Golijanin, MD²; Boris Gershman, MD^2
1Warren Alpert School of Medicine at Brown University, Providence, RI; ²Minimally Invasive Urology Institute, Providence, RI

8. Impact of Tumor, Treatment and Access on Outcomes in Bladder Cancer: Can Equal Access Overcome Race-based Differences in Survival?
Alexander P. Cole, MD¹; Sean A. Fletcher, BS¹; Marieke Krimphove, MD²; Brandon A. Mahal, MD¹; Paul L. Nguyen, MD¹; Stuart R. Lipsitz, ScD¹; Mark A. Preston, MD, MPH¹; Adam S. Kibel, MD¹; Quoc-Dien Trinh, MD^1
1Brigham & Women's Hospital, Boston, MA; ²University of Frankfurt, Frankfurt Main, Germany

9. Urine Testing for Prostate Cancer Screening: Outcomes Data from a Massachusetts Suburban Community Setting for the DLX1/HOXC6 mRNA Urine Test
Michael Geffin, MD
Greater Boston Urology, Dedham, MA

10. Impact of Multi-Morbidity on Clinician Estimates of Life Expectancy among Men with Urological Cancers: A Pilot Assessment
Cynthia P. Leung, MD; Alexander S. Chiu, MD; Michael S. Leapman, MD
Yale University, New Haven, CT

COFFEE BREAK
Ballroom B

PANEL I: Prostate Cancer Genomics
Ballroom C
Moderator: Preston C. Sprenkle, MD
Panelists: Lawrence M. Dagrosa, MD; Douglas M. Dahl, MD; Anoop M. Meraney, MD

CONCURRENT SOCIOECONOMIC SESSION
Meeting Room 26/27

Medical Liability - Current Threat Assessment
Introduction: Kevan Sternberg, MD

Sally Haggerty, Esq

Employment Contracts - The Essentials
Moderator: Anurag K. Das, MD
Panelists: Susan R. Huntington, J.D.; Dicken S. C Ko, BSc, MD; Ravi Kacker, MD; Andy Boylan, MD

SCIENTIFIC SESSION II: PEDIATRICS/STONES
Ballroom C (6 minute presentation, 2 minute discussion)
Moderators: Anne G. Dudley, MD; Frank J. Penna, MD

11. A Single-institution Series of Botulinum Toxin Injection for Refractory Neurogenic Bladder in Children
Didi Theva, MD¹; Archana Rajender, MD¹; Bartley Cilento, MD²; Stuart Bauer, MD^2
1Boston Medical Center, Boston, MA; ²Boston Children's Hospital, Boston, MA

12. Predictors of Renal Compromise in the Young Spina Bifida Population
Gina N. Tundo, MD; Lael Reinstatler, MD; Adam R. Weinstein, MD; Bridget A. Logan, APRN; Frank J. Penna, MD
Dartmouth Hitchcock, Lebanon, NH

13. Delayed Return of Ejaculatory Function in Adolescent Males Treated with RPLND and Adjuvant Therapy for Paratesticular Rhabdomyosarcoma
James Rague, MD¹; Briony Varda, MD²; Andrew Wagner, MD³; Richard Lee, MD².
¹Boston Medical Center, Boston, MA; ²Boston Children's Hospital, Boston, MA; ³Beth Israel Deaconess Medical Center, Boston, MA

14. The Use of Recombinant Factor VIIa (NovoSeven®) for Unexplained Bleeding after Genital Surgery
Danielle A. Velez, MD; Bradley Denardo, MD; Anthony Caldamone, MD; Liza Aguiar, MD
Brown University, Providence, RI

15. Use of Induction and Maintenance Intravesical BCG in a Pediatric Patient with High-grade, Non-muscle Invasive Bladder Cancer
James Rague, MD¹; Richard Lee, MD^2
1Boston Medical Center, Boston, MA; ²Boston Children's Hospital, Boston, MA

*16. Gender Equivalence in Prevalence of Nephrolithiasis Among Working and Reproductive-Aged U.S. Adults
Gina N. Tundo, MD¹; Sari Khaleel, MD²; Vernon Pais, MD^1
1Dartmouth Hitchcock, Lebanon, NH; ²University of Minnesota, Minneapolis, MN

17. Perioperative Outcomes of Ureteroscopic Laser Lithotripsy with a Single-Use Disposable Ureteroscope
Ohad Kott, MD; Jorge Pereira, MD; Timothy Wright, BS; Eric Jung, MD; Meredith Wasserman, MD; Alejandra Balen, MD; Paul Bower, MD; Christopher Tucci, CURN; Gyan Pareek, MD
Brown University, Providence, RI

18. Evaluating the Rising Use of Ureteroscopy in New England among Medicare Beneficiaries
Amanda R. Swanton, MD, PhD; Gina N. Tundo, MD; Vernon M. Pais, Jr., MD
Dartmouth-Hitchcock Medical Center, Lebanon, NH

19. Association Between Nutritional Habits and Nephrolithiasis Among U.S. Adults
Kinan Bachour, BS; Michael E. Rezaee, MD; MPH; Vernon M. Pais, Jr., MD
Dartmouth-Hitchcock Medical Center, Lebanon, NH

20. Effect of Seasonal Variation on the Incidence of Urolithiasis at an Urban Academic Medical Center
Gianpaolo Carpinito, BA; Alysen Vilhena, BA; David S. Wang, MD; Richard K. Babayan, MD; Shaun E. Wason, MD
Boston University School of Medicine, Boston, MA

21. Regional Variation in Rate of SWL Utilization among Patients with Nephrolithiasis
Gina N. Tundo, MD; Vernon M. Pais, Jr., MD
Dartmouth Hitchcock, Lebanon, NH

LUNCH SYMPOSIUM (Non-CME)
Meeting Room 26/27

STATE OF THE ART LECTURE I
Ballroom C
The Surgeon's Role in the Opioid Crisis
Speaker: Richard J. Barth, Jr, MD

SCIENTIFIC SESSION III: GENERAL/BEST PRACTICES
Ballroom C (6 minute presentation, 2 minute discussion)
Moderators: Mitchell H. Bamberger, MD, FACS; Simone Thavaseelan, MD

22. First Time, Real World Experience with the UroLift® Device Closely Mimics the LIFT Trial Data: a Single Surgeon Experience
Campbell F. Bryson, MD; Daniel Kellner, MD
Yale New Haven Hospital, New Haven, CT

23. Comparing Physician Retention in State of Training by Subspecialty Surgical Field and Sex
Jennifer Fantasia, MD; Boris Gershman, MD; Simone Thavaseelan, MD
Brown University/Rhode Island Hospital, Providence, RI

24. Analyzing the Cost-Effectiveness of Six Therapies for Treating Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia
Andrew J. Tompkins, MD¹; James C. Ulchaker, MD²; Melissa S. Martinson, PhD³.
¹Brown University, Providence, RI; ²Cleveland Clinic, Cleveland, OH; ³Technomics Research, Minneapolis, MN

25. Overuse of Cystoscopic Surveillance Among Patients with Low-risk Non-muscle-Invasive Bladder Cancer - A National Study of Patient, Provider, and Facility Characteristics
David S. Han, BS¹; Amanda R. Swanton, MD; PhD¹, Kristine E. Lynch, MS, PhD², Ji Won Chang, MPH², Brenda Sirovich, MD; MS¹, Douglas J. Robertson, MD; MPH¹, John D. Seigne, MB¹, Philip P. Goodney, MD; MS¹, Florian R. Schroeck, MD; MS¹.
¹Dartmouth-Hitchcock Medical Center, Lebanon, NH; ²VA Salt Lake City Health Care System and University of Utah, Salt Lake City, UT

26. Operating Room Efficiency Improves with Increasing Staff Experience and Structured Pre-operative Briefing
Adam Ludvigson, MD; Christina Gentile, MPH; Johann Ingimarsson, MD
Maine Medical Center, Portland, ME

27. Convective Water Vapor Thermal Therapy: 3-Year Durable Outcomes of a Randomized Controlled Study for Treatment of Lower Urinary Tract Symptoms due to Benign Prostatic Hyperplasia
Andrew J. Tompkins, MD¹; Kevin T. McVary, MD²; Claus G. Roehrborn, MD³.
¹Brown University, Providence, RI; ²Southern Illinois University School of Medicine, Springfield, IL; ³University of Texas Southwestern Medical Center, Dallas, TX

28. Transurethral Thulium Laser Prostatectomy in the Outpatient Setting: Benefits and Outcomes at a Single Center in the United States
Curran Uppaluri, BS; Theodore Cisu, BS; David Sobel, MD; Richard Grunert, MD FACS.
University Of Vermont, Burlington, VT

29. Aqua-Ablation for BPH - Subgroup Examination
Mark Plante, MD, FRCS, FACS
UVM, Burlington, VT

30. Long Term Outcomes of Expectant Management in Patients with Incomplete Bladder Emptying & Chronic Urinary Retention
Alejandro Abello, MD; William C. DeWolf, MD, FACS, Anurag K. Das, MD, FACS
Beth Israel Deaconess Medical Center, Boston, MA

31. How Robust are the Results of Urologic Studies? Applying the P-value Fragility Index to Urologic Studies
Kristian Stensland, MD, MPH¹; Navneet Ramesh, BA²; Mark Broadwin, BA²; Jonathan Batty, MBChB, MPH³, David Canes, MD^1
1Lahey Hospital and Medical Center, Burlington, MA; ²Tufts University School of Medicine, Boston, MA; ³University Hospitals Coventry and Warwickshire, Coventry, United Kingdom

32. Concurrent Urologic Surgeries Increase the Risk of Infection: A National Database Study
Valary T. Raup, MD¹; Ramy Abou Ghayda, MD¹; Abraham Chiang, MD¹; Julie Szymaniak, MD¹; Steven L. Chang, MD¹; Benjamin I. Chung, MD²; Martin Kathrins, MD^1
1Brigham and Women's Hospital, Harvard Medical School, Boston, MA; ²Stanford Medicine, Palo Alto, CA

CONCURRENT POSTER SESSION I: BASIC/TRANSLATIONAL SCIENCE
Meeting Room 22/23 (3 minute presentation, 2 minute discussion)
Moderators: Jesse D. Sammon, MD; Quoc-Dien Trinh, MD

P1. The Intrinsic Nervous System of the Ureter
Alberto Pieretti, MD; Emily Arciero, BS; Ryo Hotta, MD; Allan M Goldstein, MD
Massachusetts General Hospital, Brookline, MA

P2. microRNA Profiles in Stage I Clear Cell Renal Cell Carcinoma Predicts Progression to Metastatic Disease
Matthew J. Moynihan, MD, MPH; Travis Sullivan, MS, Jared Schober, MD; Marc Calabrese, MD; Ariel Fredrick, MD; Eric Burks, MD; David Canes, MD; Kimberly Rieger-Christ, PhD
Lahey Clinic, Burlington, MA

P3. Analysis of Urinary Extracellular Vesicles in Stone Formers Reveals Potential Target Proteins in the Formation of Nephrolithiasis
Ohad Kott, MD¹; Jorge Pereira, MD¹; Xuerong Wen, PhD², Nagib Ahsan, PhD³; Jie Tang, MD⁴; Gyan Pareek, MD^1
1Minimally Invasive Urology Institute, The Miriam Hospital, Providence, RI; ²University of Rhode Island, Kingston, RI; ³Department of Biology and Medicine, Brown University, Providence, RI; ⁴Rhode Island Hospital, Providence, RI

P4. MicroRNA Expression Profiles in Biopsy Specimens of Upper Tract Urothelial Carcinoma as a Reflection of Tumor Grade and Stage: a Tool for Clinical Decision Making
Eric G. Katz, MD¹; Brendan Browne, MD¹; Chintan K. Patel, MD¹; Travis Sullivan, MS¹, Eric J. Burks, MD¹; Jay D. Raman, MD²; Joshua Warrick, MD²; David Canes, MD¹; Kimberly M. Rieger-Christ, PhD^1
1Lahey Hospital and Medical Center, Burlington, MA; ²Penn State Hershey Medical Center, Hershey, PA

P5. Androgenic to Estrogenic Switch in the Prostate Gland of Overweight Patients
Zongwei Wang, PhD¹, Libing Hu, MD¹; Shulin Wu, MD¹; Shahin Tabetabaei, MD¹; Chin-Lee Wu, MD¹; Aria F. Olumi, MD^2
1Massachusetts General Hospital, Boston, MA; ²Beth Israel Deaconess Medical Center, Boston, MA

P6. Preclinical Study of Intraprostatic Ethanol Injection via a Microporous Needle: Correlation of Injected Volume and Lesion Size
Tyler Oe, BA¹; Matthew Sommers, BA¹; Benjamin King, MD¹; Tarjei Bern Aaser, MD²; Eva Kildall Hejbøl, BSc²; Henrik Daa Schrøder, MD, PhD²; Mark Plante, MD¹; Peter Zvara, MD; PhD^2
1Larner College of Medicine at the University of Vermont, Burlington, VT; ²University of Southern Denmark, Odense, Denmark.

P7. Synthetic TGF-?1/Smad Oligodeoxynucleotide Attenuated Renal Fibrosis via Regulation of both Epithelial and Endothelial Mesenchymal Transition (EMT/Endomt) in Unilateral Ureteral Obstruction
Mi-Gyeong Gwon, MS; Hyun-Jin An, PhD; Jung-Yeon Kim, PhD; HyeMin Gu, BS; Kwan-Kyu Park, MD
Catholic University of Daegu, Daegu, Korea, Republic of

P8. Identification of the Core Methylated CpG Regions Responsible for Silencing of steroid-5-alpha-reductase 2 (SRD5A2) in Human Prostate
Zongwei Wang, PhD¹; Hongbo Wang, PhD¹, Rongbin Ge, MD; PhD²; Shulin Wu, MD¹; Shahin Tabetabaei, MD¹; Chin-Lee Wu, MD; PhD¹; Aria F. Olumi, MD^3
1Massachusetts General Hospital, Boston, MA; ²UMass Memorial Medical Center, Worcester, MA; ³Beth Israel Deaconess Medical Center, Boston, MA

P9. Effects of Isoliquiritigenin (ISL) and [6]-Gingerol on Invasive Bladder Cancer
Sanjna Das, High School; Travis Sullivan, MS; Kimberly Rieger-Christ, PhD
Lahey Hospital & Medical Center, Burlington, MA

P10. Robotic Dismembered Pyeloplasty Surgical Simulation using a 3D-printed Silicone-based Model: Development, Face Validation, and Crowdsourced Learning Outcomes Assessment
Hersh Bendre, BSc; Archana Rajender, MD; Phil Barbosa, MD; Shaun Wason, MD
Boston University School of Medicine, Boston, MA

P11. Anti-fibrotic Effects of Bee Venom and its Major Component Melittin in an Animal Model of Unilateral Ureteral Obstruction
Hyun-Jin An, PhD; Jung-Yeon Kim, PhD; Mi-Gyeong Gwon, MS; HyeMin Gu, BS; Kwan-Kyu Park, MD
Catholic University of Daegu, Daegu, Korea, Republic of

P12. Lichen Sclerosus of the Urethra, Penile Skin and Vulva: 3 Distinct Disease Processes
Alison Levy, MD¹; Kristian Stensland, MD¹; Jennifer Bennett, MD¹; Brendan Browne, MD¹; Ariel Fredrick, MD¹; Travis Sullivan, PhD¹, Jason Badrinarain, MSc², Jorge Yao, MD²; Kimberly Rieger-Christ, PhD¹, Alex Vanni, MD^1
1Lahey Hospital, Burlington, MA; ²Pathline Emerge, Ramsey, NJ

P13. Metabolomic Evaluation of MRI-US Fusion Biopsies Differentiates Malignant from Benign
Adam S. Feldman, MD, MPH; Lindsey Vandergrift, BA; Taylor Fuss, BA; Emily Decelle, BA; Shulin Wu, PhD, Chris Dietz, PhD, Felix Ehret, PhD, Sarah Dinges, BA; Yannick Berker, PhD, Chin-Lee Wu, MD; PhD, Leo Cheng, PhD
Massachusetts General Hospital, Boston, MA

P14. Evaluation of Urine Bacterial DNA Isolation Protocols for Sequencing Analysis of the Urinary Microbiome
Matthew J. Moynihan, MD, MPH; Travis Sullivan, MS; Kimberly Rieger-Christ, PhD
Lahey Clinic, Burlington, MA

P15. The State of PSA screening in Male to Female Transgender Patients
Jorge Pereira, MD¹; Ohad Kott, MD²; Keara Decotiis, MD¹; Gyan Pareek, MD¹; Boris Gershman, MD¹; Joseph Renzulli, MD^1
1Warren Alpert School of Medicine at Brown University, Division of Urology, Providence, RI; ²The Minimally Invasive Urology Institute at The Miriam Hospital, Providence, RI

COFFEE BREAK
Ballroom B

AUA Research Update
Ballroom C
Toby C. Chai, MD

PANEL II: Competency-Based Training in Urology
Ballroom C
Moderator: Ryan Dorin, MD
Panelists: Marc D. Manganiello, MD; Andrew A. Wagner, MD; Alvin Goh, MD

AUA GUIDELINES: LUTS Associated with BPH
Ballroom C
Harris E. Foster, Jr., MD

PANEL III: Integrating Novel BPH Treatments into Current Practice
Ballroom C
Moderator: Jessica A. Mandeville, MD
Panelists: Thomas M. Buckley, MD; Anthony Kim, MD; Mark Plante, MD; Richard Alexander, MD

WELCOME RECEPTION IN EXHIBIT HALL
Ballroom B

REGISTRATION DESK
Ballroom Foyer

SPEAKER READY ROOM
Meeting Room 21

CONTINENTAL BREAKFAST, VISIT EXHIBITS
Ballroom B

EXHIBIT HALL
Ballroom B

LASER COURSE DIDACTIC SESSION*
Meeting Room 26/27
Chair: Lori B. Lerner, MD

*This session is a prerequisite for those interested in attending Sunday morning's hands-on laser session.

HOSPITALITY SUITE
Capitol 1 (Marriott Hotel)

PANEL IV: Complex Cases in Urinary Incontinence
Ballroom C
Moderator: Richard T. Kershen, MD
Panelists: Elodi Dielubanza, MD; Arthur P. Mourtzinos, MD

SCIENTIFIC SESSION IV: ANDROLOGY/INCONTINENCE/FEMALE UROLOGY
Ballroom C (6 minute presentation, 2 minute discussion)
Moderators: Brooke A. Harnisch, MD; Gillian Stearns, MD

33. Robotic Sacrocolpopexy for the Management of Pelvic Organ Prolapse: An Update on Quality of Life Outcomes
Annah J. Vollstedt, MD¹; William Meeks, MA²; Veronica Triana, MD^3
1Dartmouth Hitchcock Medical Center, Lebanon, NH; ²Department of Data Management & Statistical Analysis, American Urological Association, Linthicum, MD; ³Concord Hospital Center for Urologic Care, Concord, NH

34. Postoperative Penile Prosthesis Pain: Is it Worse in Diabetic Patients?
Michel Apoj, BS¹; Mark Biebel, MD¹; Archana Rajender, MD¹; Dayron Rodriguez, MD; MPH¹; Didi Theva, MD¹; Martin Gross, MD²; Ricardo Munarriz, MD^1
1Boston University School of Medicine, Boston, MA; ²Dartmouth-Hitchcock Medical Center, New Hampshire, NH

35. Virtue Sling is Ineffective as Salvage for Failed AdVance Sling in Treating Male Stress Urinary Incontinence
Thomas Kishkovich, ScB; Madeline Cancian, MD; Kennon S. Miller, MD
Brown University, Providence, RI

36. Resident Simulation Training Courses (Cadaver Lab): An Assessment Survey
Michel Apoj, BS¹; Mark Biebel, MD¹; Archana Rajender, MD¹; Dayron Rodriguez, MD, MPH¹; Aaron Lentz, MD²; Ricardo Munarriz, MD^1
1Boston University School of Medicine, Boston, MA; ²Duke Raleigh Hospital, Raleigh, NC

37. Emerging Data Regarding Fungal Infections of Inflatable Penile Prostheses
Martin S. Gross, MD¹; Gerard D. Henry, MD²; Stanton C. Honig, MD³; Peter J. Stahl, MD⁴; Arthur L. Burnett, MD⁵; Pedro P. Maria, DO⁶; Nelson E. Bennett, Jr., MD⁷; Rafael E. Carrion, MD⁸; Tobias S. Kohler, MD⁹; Ricardo M. Munarriz, MD^10
1Dartmouth-Hitchcock Medical Center/Dartmouth-Hitchcock Keene, Keene, NH; ²Ark-La-Tex Urology, Shreveport, LA; ³Yale University School of Medicine, New Haven, CT; ⁴Columbia University College of Physicians and Surgeons, New York City, NY; ⁵The Johns Hopkins University School of Medicine, Baltimore, MD; ⁶Albert Einstein College of Medicine, New York City, NY; ⁷Northwestern University Feinberg School of Medicine, Chicago, IL; ⁸University of South Florida Morsani College of Medicine, Tampa, FL; ⁹Mayo Clinic, Rochester, MN; ¹⁰Boston University School of Medicine, Boston, MA

38. Pre-Operative Urodynamic Evaluation in Female Medicare Patients Undergoing a Stress Urinary Incontinence Procedure: Rates Before and After the Value Trial
Annah J. Vollstedt, MD; Rachel Moses, MD; MPH; E. Ann A. Gormley, MD
Dartmouth Hitchcock Medical Center, Lebanon, NH

39. The Use of Flurbiprofen in Treatment of Pyospermia
Valary T. Raup, MD; Julie Szymaniak, MD; Ramy Abou Ghayda, MD; Martin Kathrins, MD
Brigham and Women's Hospital, Harvard Medical School, Boston, MA

40. Voiding Dysfunction and Risk Factors for Complications in Multiple Sclerosis
Alejandro Abello, MD; Anurag K. Das, MD FACS
Beth Israel Deaconess Medical Center, Brookline, MA

41. Trends in Penile Prosthesis Implantation and Predictors of Removal
Kai Li, MD¹; Eileen Brandes, MD²; Steven L. Chang, MD³; Benjamin I. Chung, MD⁴; Ye Wang, BS³; Jairam R. Eswara, MD^3
1Massachusetts General Hospital, Boston, MA; ²Harvard Medical School, Boston, MA; ³Brigham and Women's Hospital, Boston, MA; ⁴Stanford Hospital, Stanford, CA

42. Closed Suction Drain Outputs at 12 and 24 Hours after Virginal Three-Piece Inflatable Penile Prosthesis Surgery
Michel Apoj, BS¹; Mark Biebel, MD¹; Archana Rajender, MD¹; Dayron Rodriguez, MD, MPH¹; Martin Gross, MD²; Ricardo Munarriz, MD^1
1Boston University School of Medicine, Boston, MA; ²Dartmouth-Hitchcock Medical Center, New Hampshire, NH

43. Multicenter Investigation on the Influence of Climate in Penile Prosthesis Infection
Martin S. Gross, MD¹; Jason M. Greenfield, MD²; Laurence A. Levine, MD³; Joseph Alukal, MD⁴; William P. Conners, III, MD⁵; Cigdem Tanrikut, MD⁶; Stanton C. Honig, MD⁷; Nelson E. Bennett, Jr., MD⁸; Run Wang, MD⁹; Paul E. Perito, MD¹⁰; Peter J. Stahl, MD¹¹; Mariano Rosselló Gayá, MD¹²; Mariano Rosselló Barbará, MD¹²; Edward Gheiler, MD¹³; David J. Ralph, MD¹⁴; Doron S. Stember, MD¹⁵; Rafael E. Carrion, MD¹⁶; Tobias S. Kohler, MD¹⁷; Pedro P. Maria, DO¹⁸; William O. Brant, MD¹⁹; Bruce B. Garber, MD²⁰; Arthur L. Burnett, MD²¹; J. Francois Eid, MD²²; Gerard D. Henry, MD²³; Ricardo M. Munarriz, MD^24
1Dartmouth-Hitchcock Medical Center/Dartmouth-Hitchcock Keene, Keene, NH; ²Urology Associates of North Texas, Arlington, TX; ³Rush Medical College, Chicago, IL; ⁴New York University School of Medicine, New York City, NY; ⁵Beth Israel Deaconess Medical Center, Boston, MA; ⁶University of Maryland School of Medicine, Baltimore, MD; ⁷Yale University School of Medicine, New Haven, CT; ⁸Northwestern University Feinberg School of Medicine, Chicago, IL; ⁹McGovern Medical School at The University of Texas Health Science Center at Houston, Houston, TX; ¹⁰Perito Urology, Coral Gables, FL; ¹¹Columbia University College of Physicians and Surgeons, New York City, NY; ¹²Instituto Medico Rosselló, Madrid, Spain, ¹³Urology Specialists, Hialeah, FL; ¹⁴University College London, London, United Kingdom, ¹⁵Mount Sinai Hospital, New York City, NY; ¹⁶University of South Florida Morsani College of Medicine, Tampa, FL; ¹⁷Mayo Clinic, Rochester, MN; ¹⁸Albert Einstein College of Medicine, New York City, NY; ¹⁹Intermountain Medical Center, Salt Lake City, UT; ²⁰Hahnemann University Hospital, Philadelphia, PA; ²¹The Johns Hopkins University School of Medicine, Baltimore, MD; ²²Advanced Urological Care, New York City, NY; ²³Ark-La-Tex Urology, Shreveport, LA; ²⁴Boston University School of Medicine, Boston, MA

COFFEE BREAK, VISIT EXHIBITS
Ballroom B

PANEL V: Modern Priapism Management
Ballroom C
Moderator: Ricardo M. Munarriz, MD
Panelists: William Conners, III, MD; Martin S. Gross, MD; Ajay Nehra, MD

SCIENTIFIC SESSION V: TRAUMA/RECONSTRUCTION
Ballroom C (6 minute presentation, 2 minute discussion)
Moderators: Jairam R. Eswara, MD; Alex J. Vanni, MD

44. Evaluation of Urethral Stricture Tissue Protein Expression Profiles as Predictors of Stricture Recurrence
Alison Levy, MD; Matthew J. Moynihan, MD; MPH; Jennifer Bennett, MD; Travis Sullivan, MS, Kristian Stensland, MD; MPH; Brendan Browne, MD; Ariel Fredrick, MD; Kimberly Rieger-Christ, PhD, Alex J. Vanni, MD
Lahey Clinic, Burlington, MA

45. Epidemiology of Penile Fractures in the Emergency Room Setting in the United States
Dayron Rodriguez, MD, MPH¹; Kai Li, MD²; Michel Apoj, BS¹; Archana Rajender, MD¹; Nannan Thirumavalavan, MD³; Ricardo Munarriz, MD^1
1Boston Medical Center, Boston University School of Medicine, Boston, MA; ²Massachusetts General Hospital, Boston, MA; ³Baylor College of Medicine, Houston, TX

46. Perioperative Outcomes of Male One-Stage Urethroplasty; Outcomes from a National Prospective Database
Valary T. Raup, MD; Pamela W. Lu, MD; Bjoern Loeppenberg, MD; Christian Meyer, MD; Malte Vetterlein, MD; Quoc-Dien Trinh, MD; Jairam Eswara, MD; Julie Szymaniak, MD
Brigham and Women's Hospital, Harvard Medical School, Boston, MA

47. Risk of Post-Operative Venous Thromboembolism in Urethroplasty
Matthew J. Moynihan, MD, MPH; Alex J. Vanni, MD
Lahey Clinic, Burlington, MA

48. Predictors of Hospital Transfer for Patients Presenting with Penile Fractures in Emergency Departments in the United States
Dayron Rodriguez, MD, MPH¹; Kai Li, MD²; Michel Apoj, BS¹; Archana Rajender, MD¹; Nannan Thirumavalavan, MD³; Ricardo Munarriz, MD¹.
¹Boston Medical Center, Boston University School of Medicine, Boston, MA; ²Massachusetts General Hospital, Boston, MA; ³Baylor College of Medicine, Houston, TX

49. "Shreddin' the Gnar”: An Analysis of Winter Sport Related Renal Trauma
Robin Djang, MD; Rachel Moses, MD; Vernon M. Pais, Jr., MD
Dartmouth Hitchcock Medical Center, Lebanon, NH

50. Pathophysiology of Lichen Sclerosus Urethral Strictures: The Role of Inflammation and Viral Infection
Alison Levy, MD¹; Kristian Stensland, MD¹; Jennifer Bennett, MD¹; Brendan Browne, MD¹; Ariel Fredrick, MD¹; Travis Sullivan, PhD¹, Jason Badrinarain, MSc², Jorge Yao, MD²; Kimberly Rieger-Christ, PhD¹, Alex Vanni, MD^1
1Lahey Hospital, Burlington, MA; ²Pathline Emerge, Ramsey, NJ

51. Perioperative Outcomes of Enterocystoplasty in Adults
Valary T. Raup, MD; Pamela W. Lu, MD; Bjoern Loeppenberg, MD; Christian Meyer, MD; Malte Vetterlein, MD; Quoc-Dien Trinh, MD; Jairam Eswara, MD
Brigham and Women's Hospital, Harvard Medical School, Boston, MA

52. Epidemiology of Genito-Urinary Foreign Bodies in the Emergency Room Setting in the United States and its association with Mental Health disorders
Dayron Rodriguez, MD, MPH; Michael Apoj, BS; Archana Rajender, MD; Ricardo Munarriz, MD
Boston Medical Center, Boston University School of Medicine, Boston, MA

53. Endoscopic Treatments Prior to Urethroplasty: Trends in Management of Urethral Stricture Disease
Matthew J. Moynihan, MD, MPH; Alex J. Vanni, MD
Lahey Clinic, Burlington, MA

54. Genitourinary Complications Associated with Transcatheter Aortic Valve Replacement
Syed Alam, BA¹, Jason K. Frankel, MD¹; Elisabeth E. Mulroy, MD¹; Richard L. Seip, PhD², Brett Hiendlmayr, MD²; Stuart Kesler, MD^2
1University of Connecticut, Farmington, CT; ²Hartford Hospital, Hartford, CT

CONCURRENT POSTER SESSION II: ONCOLOGY/PROSTATE
Meeting Room 22/23 (3 minute presentation, 2 minute discussion)
Moderators: Stuart Kesler, MD; Benjamin Ristau, MD

P16. Positive Surgical Margins Following Robotic Prostatectomy: Should Location be Considered in Planning Further Treatment?
Jacob Baber, MD; Ilene Staff, PhD, Tara McLaughlin, PhD, Joseph Tortora, MS; Joseph Wagner, MD
Hartford Hospital, Hartford, CT

*P17. Thirty Day Readmissions After Radical Cystectomy: Does the Hospital Make a Difference?
Alexander P. Cole, MD¹; Sabrina Harmouch, MD¹; Ashwin Ramaswamy, BA¹; Phillip Gild, MD²; Stuart R. Lipsitz, ScD¹; Mark Preston, MD¹; Adam S. Kibel, MD¹; Quoc-Dien Trinh, MD^1
1Brigham & Women's Hospital, Boston, MA; ²Hamburg University Hospital, Department of Urology, Hamburg, Germany

P18. Effect of Biopsy Orientation on Prostate Cancer Detection Rates Using a Modified MRI-Fusion Biopsy Template
Jack Grinnan, MD¹; Ilene Staff, PhD¹; Joseph Tortora, MS¹; Tara McLaughlin, PhD¹; Sarah Valente, MD²; Joseph Wagner, MD¹; Stuart Kesler, MD^1
1Hartford Hospital, Hartford, CT; ²University of Connecticut Health Center, Farmington, CT

P19. Predictors of Clinically Significant Prostate Cancer in Anterior Fibromuscular Stroma Lesions on Multi-Parametric Magnetic Resonance Imaging
Kamyar Ghabili Amirkhiz, MD; Richard Ho, MD; Michael Leapman, MD; Jeffrey Weinreb, MD; Peter Schulam, MD; PhD, Preston Sprenkle, MD
Yale School of Medicine, New Haven, CT

P20. Does the Number of Lymph Nodes Resected During Radical Cystectomy for Squamous Cell Carcinoma Really Matter?
Kristian Stensland, MD, MPH¹; Mark Broadwin, BA²; Lawrence Zhang, BA²; Joan Delto, MD³; Peter Chang, MD, MPH³; Andrew Wagner, MD^3
1Lahey Hospital and Medical Center, Burlington, MA; ²Tufts University School of Medicine, Boston, MA; ³Beth Israel Deaconess Medical Center, Boston, MA

P21. Heterogeneity in Early Oncologic Outcomes after Radical Prostatectomy in Men with National Comprehensive Cancer Network (NCCN) Intermediate-Risk Prostate Cancer
Kamyar Ghabili Amirkhiz, MD; Kevin Nguyen, MS, Amanda Lu, BA; Walter Hsiang, BS; Brian Shuch, MD; Michael Leapman, MD
Yale School of Medicine, New Haven, CT

P22. Predictors of Urethrovesical Leak on Cystogram after Robotic Assisted Retropubic Prostatectomy
Alexa Golden, BS¹; Kristian Stensland, MD MPH²; David Canes, MD²; Alireza Moinzadeh, MD²; Karim Hamawy, MD^2
1Tufts University School of Medicine, Boston, MA; ²Lahey Hospital and Medical Center, Burlington, MA

P23. Outcomes of MR/Ultrasound Fusion-Guided Biopsy for Men with Low Risk Prostate Cancer on Active Surveillance
Richard Ho, MD; Kamyar Ghabili Amirkhiz, MD; Michael S. Leapman, MD; Jeffrey C. Weinreb, MD; Peter G. Schulam, MD; PhD, Preston C. Sprenkle, MD
Yale School of Medicine, New Haven, CT

P24. The Prognostic Impact of a Negative Confirmatory Biopsy in Men on Active Surveillance for Prostate Cancer
Keyan Salari, MD, PhD¹, Dimitar V. Zlatev, MD¹; David Kuppermann, MD¹; Mark A. Preston, MD, MPH²; Douglas M. Dahl, MD¹; Jason A. Efstathiou, MD, DPhil¹; Michael L. Blute, MD¹; Anthony L. Zietman, MD¹; Adam S. Feldman, MD, MPH^1
1Massachusetts General Hospital, Boston, MA; ²Brigham and Women's Hospital, Boston, MA

P25. 10 Year Experience of Prostate Total and Partial Cryoablation
Louis Liou, MD, PhD¹; Carter Liou, BA²; Amanda Farrell, BA^1
1Cambridge Health Alliance, Cambridge, MA; ²Colby College, Waterville, ME

P26. IMP3 Expression Predicts Metastatic-free Survival in Patients with High-risk Renal-cell Carcinoma
Lucille Cox, BA; Brittany Berk, BA; Stephanie Bond, BA; Sana Majid, BA; Joanna Wang, BA; Alexander Miller, BA; Tong Sun, MD; Kristine Cornejo, MD; Zhong Jiang, MD; Scott Greenberg, MD; Jennifer K. Yates, MD
University of Massachusetts Medical School, Worcester, MA

P27. Impact of Pathogen Colonization on Infection of the Urinary Tract after Radical Cystectomy
Jacqueline M. Speed, MD; Elodi J. Dielubanza, MD; H. Abraham Chiang, MD; Adam S. Kibel, MD; Preston A. Mark, MD; MPH; Matthew Mossanen, MD
Brigham and Women's, Boston, MA

P28. Is Presence of a Urology Resident During Robotic Assisted Laparoscopic Radical Prostatectomy Detrimental to Outcomes?
Jacob Baber, MD; Ilene Staff, PhD, Tara McLaughlin, PhD, Joseph Tortora, MS, Joseph Wagner, MD
Hartford Hospital, Hartford, CT

P29. Trends and Morbidity for Minimally Invasive versus Open Cytoreductive Nephrectomy in the Management of Metastatic Renal Cell Carcinoma
Dimitar Zlatev, MD¹; Daniel Pucheril, MD, MBA¹; Manuel Ozambela, MD¹; Ye Wang, PhD¹; Benjamin Chung, MD, MS²; Steven L. Chang, MD MS^1
1Brigham and Women's Hospital, Boston, MA; ²Stanford University Medical Center, Stanford, CA

P30. Clinical Utility of MR/Ultrasound Fusion-Guided Biopsy in Patients With PI-RADS 2 and 3 Lesions on Active Surveillance for Low Risk Prostate Cancer
Richard Ho, MD; Kamyar Ghabili Amirkhiz, MD; Michael S. Leapman, MD; Jeffrey C. Weinreb, MD; Peter G. Schulam, MD; PhD, Preston C. Sprenkle, MD
Yale School of Medicine, New Haven, CT

LUNCH SYMPOSIUM (Non-CME)
Meeting Room 26/27

STATE OF THE ART LECTURE II
What Every Urologist Should Know About Gender Affirming Surgery
Ballroom C
Stanton Honig, MD
Yale School of Medicine, New Haven, CT

SOCIOECONOMIC SESSION
Ballroom C

Understanding Compensation Formulas
Moderator: Gregory S. Adey, MD
Panelists: Arthur E. Tarantino, MD; E. Ann Gormley, MD; Gyan Pareek, MD; Joshua Teplitzky

COFFEE BREAK, VISIT EXHIBITS
VIDEO SESSION & HISTORY OF UROLOGY
Ballroom B

Laparoscopic Inguinal Lymph Node Dissection
Douglas Ridyard, MD; Michael Lao, MD; Benjamin Ristau, MD, MHA
University of Connecticut, Farmington, CT

Excision of Intravesical Mini Sling Using an Exclusively Transurethral Approach
Hyosang A. Chiang, MD; Iwona M. Gabriel, MD; Vatche A. Minassian, MD, MPH
Brigham and Women's Hospital, Boston, MA

Robotic Assisted Retroperitoneoscopic Pyelolithotomy for Staghorn Calculus
Ruth Blum, MD¹; Ryan Dorin, MD^2
1UConn Health, Farmington, CT; ²Hartford Healthcare Medical Group, Hartford, CT

Robotic Right Radical Nephrectomy with IVC Thrombectomy
Tenny R. Zhang, BA¹; Joan C. Delto, MD²; Chintan Patel, MD³; Andrew A. Wagner, MD^2
1Harvard Medical School, Boston, MA; ²Beth Israel Deaconess Medical Center, Boston, MA; ³Lahey Clinic, Burlington, MA

Immediate Evaluation and Robot-Assisted Repair of a Urinary Injury Following Hysterectomy
Robin Djang, MD; John D. Seigne, MB
Dartmouth Hitchcock Medical Center, Lebanon, NH

AUA GUIDELINES: Antimicrobial Prophylaxis Update
Ballroom C
Harris E. Foster, Jr., MD

Lifelong Learning - an update from the ABU and the AUA
Ballroom C
Gerald H. Jordon, MD, FACS

AUA GUIDELINES: Erectile Dysfunction
Ballroom C
Mark Sigman, MD

ATTENDEE RECEPTION IN EXHIBIT HALL
Ballroom B

RESIDENT OLYMPICS
CESI, Hartford Hospital (Transportation to be provided)
Joseph R. Wagner, MD; Stuart S. Kesler, MD; Ryan Dorin, MD

REGISTRATION DESK
Ballroom Foyer

SPEAKER READY ROOM
Meeting Room 21

CONTINENTAL BREAKFAST, VISIT EXHIBITS
Ballroom B

EXHIBIT HALL
Ballroom B

ANNUAL BUSINESS MEETING, Members Only
Ballroom C

HOSPITALITY SUITE
Capitol 1 (Marriott Hotel)

CONCURRENT UROLOGY NURSES AND ADVANCED PRACTICE PROVIDERS PROGRAM
Meeting Room 26/27

PANEL V: Today's Technologies for Managing Challenging Stones
Ballroom C
Moderator: Diane E. Sacco, MD
Panelists: Johann Ingimarsson, MD; Erica H. Lambert, MD; Kevan Sternberg, MD

SCIENTIFIC SESSION VI: STONES/ENDOUROLOGY
Ballroom C (6 minute presentation, 2 minute discussion)
Moderators: Vernon M. Pais, Jr, MD; Gyan Pareek, MD

55. Investigating the Relationship between Socioeconomic Factors and Nephrolithiasis Prevalence
Kinan Bachour, BS; Amanda R. Swanton, MD; PhD; Vernon M. Pais, Jr., MD
Dartmouth-Hitchcock Medical Center, Lebanon, NH

*56. Cystinuric Stone Conversion and Associations with Medical and Surgical Interventions
Lael Reinstatler, MD, MPH¹; Cody M. Rissman, MD¹; Karen Stern, MD²; Hunt Batter, BS³, Kymora Scotland, MD; PhD⁴, Gholamreza S. Ardekani, MD; PhD⁴; Manuel Rivera, MD⁵; Ben Chew, MD⁴; Brian Eisner, MD⁶; Amy Krambeck, MD⁵; Manoj Monga, MD²; Vernon M. Pais, Jr., MD^1
1Dartmouth Hitchcock Medical Center, Lebanon, NH; ²Cleveland Clinic, Cleveland, OH; ³Harvard School of Medicine, Boston, MA; ⁴University of British Columbia, British Columbia, BC; ⁵Indiana University, Indianapolis, IN; ⁶Massachussetts General Hospital, Boston, MA

57. The Value of Planned Renal Stone Clearance at Time of Ureteroscopy for Ureteral Stones: a Comparative Effectiveness Analysis
Rajiv S. Raghavan, ABBE¹; Marie-Therese Valovska, BS¹; Vernon M. Pais, Jr., MD^2
1Geisel School of Medicine at Dartmouth, Hanover, NH; ²Dartmouth-Hitchcock Medical Center, Lebanon, NH

58. Non-obstructing Renal Stones and Their Effect on Stone-Related Quality of Life
Eric P. Raffin, MD¹; David R. Brown, BS²; Vernon M. Pais, Jr., MD^1
1Dartmouth Hitchcock Medical Center, Lebanon, NH; ²Geisel School of Medicine, Dartmouth College, Hanover, NH

59. Failure of Electronic Stent Registry: Incidence of Retained Ureteral Stents and Implications for Prevention
Robin Djang, MD; Eric P. Raffin, MD; Vernon M. Pais, Jr., MD
Dartmouth Hitchcock Medical Center, Lebanon, NH

60. Reduced Dose Computed Tomography for Urolithiasis: Stone Density and Composition
Shu Pan, MD; Jeannie J. Su, MD; Jamil Syed, MD; Christopher Moore, MD; Gary Israel, MD; Dinesh Singh, MD
Yale, New Haven, CT

*61. The use of Opioids for Stones and Ureteral Stents: Insights from an EDGE Consortium Patient Survey
Annah J. Vollstedt, MD¹; Manoj Monga, MD²; Anna Zampini, MD²; Amy Krambeck, MD³; Ojahs Shah, MD⁴; Roger Sur, MD⁵; Ben Chew, MD⁶; Brian Eisner, MD⁷; Stephanie Thompson, MD⁴; Tammer Yamany, MD⁷; Vernon Pais, MD^1
1Dartmouth Hitchcock Medical Center, Lebanon, NH; ²Cleveland Clinic, Cleveland, OH; ³Indiana University, Indianapolis, IN; ⁴Columbia Univerisity, New York, NY; ⁵University of California, San Diego, San Diego, CA; ⁶University of British Columbia, Vancouver, BC; ⁷Massachusetts General Hospital, Boston, MA

62. The Durability of Active Surveillance in Patients with Asymptomatic Kidney Stones: A Systematic Review
David S. Han, BS¹; Benjamin Cher, BS²; Dongheon Lee, BS²; Sreevaishali Rajendran, BS²; Natalie B.V. Riblet, MD, MPH³; Vernon M. Pais, Jr., MD^4
1Geisel School of Medicine at Dartmouth, Hanover, NH; ²The Dartmouth Institute for Health Policy and Clinical Practice, Lebanon, NH; ³White River Junction VA Medical Center, White River Junction, VT; ⁴Section of Urology at Dartmouth-Hitchcock Medical Center, Lebanon, NH

63. 15 Month Experience with a Non-Opioid Pathway for Postoperative Pain after Ureteroscopy
David W. Sobel, MD; Theodore Cisu, MS4, Andrew Pham, MS2, Kevan M. Sternberg, MD
University of Vermont, Burlington, VT

*64. Stent Duration and Increased Pain in the Hours after Ureteral Stent Removal: An EDGE Multi-Institutional Survey
Michael E. Rezaee, MD, MPH¹; Annah J. Vollstedt, MD¹; Rajiv Raghavan, BS¹; Manoj Monga, MD²; Anna Zampini, MD; MBA; MS², Ojas Shah, MD³; Amy Krambeck, MD⁴; Roger Sur, MD⁵; Stephanie Thompson, MS³, Tammer Yamany, MD⁶; Vernon Pais, Jr., MD^1
1Dartmouth-Hitchcock Medical Center, Lebanon, NH; ²Cleveland Clinic, Cleveland, OH; ³Columbia University, New York, NY; ⁴Indiana University, Indianapolis, IN; ⁵University of California San Diego, San Diego, CA; ⁶Massachusetts General Hospital, Boston, MA

65. Trends in Regional Narcotic and NSAID Use in Emergency Department Patients with Acute Renal Colic
Alexandra Berger, MD¹; Ye Wang, PhD¹, Benjamin Chung, MD²; Steven Chang, MD¹; George Haleblian, MD^1
1Brigham and Women's Hospital/Harvard University, Boston, MA; ²Stanford University, Palo Alto, CA

COFFEE BREAK, VISIT EXHIBITS
Ballroom B

LEADBETTER LECTURE
Ballroom C
What's New in Patient-Reported Outcomes Following Treatment for Localized Prostate Cancer?
David F. Penson, MD, MPH
Vanderbilt University Medical Center, Nashville, TN

PRESIDENTIAL ADDRESS
Ballroom C
A Urologist's Life Cycle or Jimmy Hoffa, Where Are You When We Need You
Arthur E. Tarantino, MD
Hartford HealthCare, Hartford, CT

LUNCH SYMPOSIUM (Non-CME)
Ballroom C

CONCURRENT UROLOGY NURSES AND ADVANCED PRACTICE PROVIDERS PROGRAM
Meeting Room 26/27

STATE OF THE ART LECTURE III
Role of Telemedicine in Urology
Ballroom C
Eugene Y. Rhee, MD, MBA
Kaiser Permanente, Los Angeles, CA

AUA GUIDELINES: Evaluation & Management of Testosterone Deficiency
Ballroom C
Martin Miner, MD

SCIENTIFIC SESSION VII: PROSTATE
Ballroom C (6 minute presentation, 2 minute discussion)
Moderators: Joseph F. Renzulli, II MD; David F. Penson, MD, MPH

66. Do Accountable Care Organizations Impact Prostate Cancer Screening?
Alexander P. Cole, MD¹; Ashwin Ramaswamy, BA¹, Anna Krasnova, MS¹; Maxine Sun, PhD, MPH¹; David F. Friedlander, MD, MPH¹; Jesse D. Sammon, DO³; Joel Weissman, PhD¹; Stuart R. Lipsitz, ScD¹; Adam S. Kibel, MD¹; Quoc-Dien Trinh, MD^1
1Brigham and Women's/Dana Farber Cancer Center, Boston, MA; ³Maine Medical Center, Portland, ME

67. Optimizing the Threshold for Pelvic Lymph Node Dissection in the Contemporary Surgical Management of Prostate Cancer
Danielle A. Velez, MD; Ali Amin, MD; Jorge Pereira, MD; Paul Bower, MD; Dragan Golijanin, MD; Boris Gershman, MD; Joseph Renzulli, MD
Brown University / Rhode Island Hospital, Providence, RI

68. Specialist Density and Surgery vs. Radiation Therapy for Prostate Cancer: Does Supply Induce Demand?
Lael Reinstatler, MD, MPH¹; Elias S. Hyams, MD^2
1Dartmouth Hitchcock Medical Center, Lebanon, NH; ²Columbia University, New York, NY

69. PROSPER: A Phase 3, Randomized, Double-Blind, Placebo (PBO)-Controlled Study of Enzalutamide (ENZA) in Men With Nonmetastatic Castration-Resistant Prostate Cancer (M0 CRPC)
Fred Saad, MD¹; Karim Fizazi, MD²; Maha Hussain, MD³; Per Rathenborg, MD⁴; Neal Shore, MD⁵; Eren Demirhan, PhD, MBA⁶, Katharina Modelska, MD; PhD⁶, De Phung, BSc⁷, Andrew Krivoshik, MD; PhD⁷, Cora N. Sternberg, MD^8
1Centre hospitalier de l'Université de Montréal, Montréal, QC; ²Institut Gustave Roussy, University of Paris Sud, Villejuif, France, ³Northwestern University, Chicago, IL; ⁴Herlev Hospital, Herlev, Denmark, ⁵Carolina Urologic Research Center, Myrtle Beach, SC; ⁶Pfizer, Inc., San Francisco, CA; ⁷Astellas Pharma, Inc., Northbrook, IL; ⁸San Camillo and Forlanini Hospitals, Rome, Italy

70. Prognostic Impact of Increased Prostate-Specific Antigen Density in Men on Active Surveillance for Prostate Cancer
Dimitar Zlatev, MD; Keyan Salari, MD, PhD; David Kuppermann, MD; Daniel Pucheril, MD, MBA; Michael L. Blute, MD; Adam Feldman, MD
Massachusetts General Hospital, Boston, MA

PANEL VII: Controversies in Testosterone Replacement Therapy
Ballroom C
Moderator: Jared Bieniek, MD
Panelists: Stanton C. Honig, MD; Andrew McCullough, MD; Martin Miner, MD

SOCIOECONOMIC SESSION
Navigating a Career in Urology – Academics, Health Systems, and Private Practice
Ballroom C
Moderator: Leslie Rickey, MD
Academic medicine: David F. Penson, MD, MPH
Health system/hospital: Eugene Y. Rhee, MD, MBA
Large group practice: Michael J. Curran, MD
Small group practice: Guy J. Manetti, MD

PRESIDENT'S BANQUET
Wadsworth Atheneum Museum of Art

RESIDENT EDUCATION PROGRAM
Chair: Steven J. Shichman, MD

LASER COURSE HANDS-ON SESSION*
Chair: Lori B. Lerner, MD

*Attendees must attend Friday morning's didactic session to attend the hands-on laser session.

Hands-On Topic Rotation Stations
Chair: Steven J. Shichman, MD